Related Experiment Video
Updated: Jul 1, 2025

07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.2K
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study.
Roberto Angioli1, Marco Santonico2, Giorgio Pennazza3
1Unit of Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
Diagnostics (Basel, Switzerland)
|March 13, 2024
Summary
Researchers explored using electronic noses and e-tongues to detect ovarian cancer (OC) in breath, urine, blood, and plasma. These novel methods show promise for earlier and more accurate ovarian cancer diagnosis.
Area of Science:
- Oncology
- Biomedical Engineering
- Analytical Chemistry
Background:
- Ovarian cancer (OC) is a leading cause of cancer death in women, often diagnosed late due to lack of effective screening.
- Current detection methods including clinical examination, ultrasound, and biomarkers like CA 125 and HE4 have limitations in sensitivity and specificity, frequently missing early-stage disease.
Purpose of the Study:
- To investigate the novel application of electronic nose and electronic tongue technologies for ovarian cancer detection.
- To evaluate the potential of these devices in analyzing volatile organic compounds (VOCs) from various biological samples.
Main Methods:
- Utilized an electronic nose to detect VOCs in breath samples.
- Employed an electronic tongue to analyze VOCs in liquid samples including urine, blood, and plasma.
- Compared the diagnostic performance of these novel sensor technologies against existing methods.
Main Results:
- The study demonstrated the feasibility of using electronic nose and e-tongue for ovarian cancer detection.
- Preliminary findings suggest these devices can identify VOC patterns associated with OC across different sample types.
- This research pioneers the use of these biosensor technologies for OC diagnostics beyond breath analysis.
Conclusions:
- Electronic nose and e-tongue technologies offer a promising new avenue for early ovarian cancer detection.
- Further research and validation are warranted to establish their clinical utility in diagnosing ovarian cancer from breath, urine, blood, and plasma.

